Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Metabolic abnormalities: high-density lipoproteins.

Philip Barter1

  • 1The Heart Research Institute, 145 Missenden Road, Camperdown, Sydney NSW 2050, Australia. p.barter@hri.org.au

Endocrinology and Metabolism Clinics of North America
|May 26, 2004
PubMed
Summary

Metabolic syndrome often involves low high-density lipoprotein (HDL) cholesterol. This review explores HDL

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prevalence of plasma lipid disorders with an emphasis on LDL cholesterol in selected countries in the Asia-Pacific region.

Lipids in health and disease·2021
Same author

Waist circumference as a vital sign in clinical practice: a Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity.

Nature reviews. Endocrinology·2020
Same author

Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement.

The lancet. Diabetes & endocrinology·2019
Same author

HDL cholesterol and ASCVD risk stratification: A debate.

Atherosclerosis·2019
Same author

Expert opinion on the applicability of dyslipidemia guidelines in Asia and the Middle East.

International journal of general medicine·2018
Same author

Triglyceride-Rich Lipoprotein Cholesterol and Risk of Cardiovascular Events Among Patients Receiving Statin Therapy in the TNT Trial.

Circulation·2018

Area of Science:

  • Cardiovascular Health
  • Metabolic Disorders
  • Lipid Metabolism

Background:

  • Metabolic syndrome is characterized by dyslipidemia, including elevated triglycerides and low HDL cholesterol.
  • Low high-density lipoprotein (HDL) cholesterol is a key feature of metabolic syndrome.
  • HDL particles in metabolic syndrome are often smaller and denser, impacting their function.

Purpose of the Study:

  • To provide an overview of high-density lipoprotein (HDL) structure, metabolism, and cardioprotective functions.
  • To examine HDL concentration and subpopulation distribution in metabolic syndrome.
  • To discuss potential mechanisms, consequences, and therapeutic targets for low HDL in metabolic syndrome.

Main Methods:

  • Literature review of HDL structure and metabolism.
  • Analysis of studies on HDL in metabolic syndrome.
  • Discussion of proposed pathomechanisms and clinical implications.

Main Results:

  • Individuals with metabolic syndrome typically exhibit low HDL cholesterol levels.
  • HDL subpopulations and their functions may be altered in metabolic syndrome.
  • Mechanisms contributing to low HDL in this condition are complex and multifactorial.

Conclusions:

  • Low HDL cholesterol is a significant component of metabolic syndrome's lipid profile.
  • Understanding HDL's role is crucial for managing cardiovascular risk in metabolic syndrome.
  • Further research is needed to determine if targeting low HDL is an effective therapeutic strategy.

Related Experiment Videos